On the one hand, it could be assumed that ApoE4 carriage increases the speed of amyloid plaque accumulation in AD patients; in that case, MRI+CLP would have better sensitivity in early stage AD in ApoE4 carriers. This evidence concerns the gene APOE and Alzheimer disease.